Neurology Minute
1,957 episodes — Page 26 of 40
Parasitic Infections of the Peripheral Nervous System - Part 2
In part 2 of a 2 part series, Hector H. Garcia, MD, PhD, discusses his article, "Parasitic Infections of the Nervous System" from the August Neuroinfectious Disease Continuum issue. This article and the accompanying Continuum Audio interview are available to all at continpub.com/ParaInfect until December 10, 2021.
Parasitic Infections of the Peripheral Nervous System - Part 1
In part 1 of a 2 part series, Hector H. Garcia, MD, PhD, discusses his article, "Parasitic Infections of the Nervous System" from the August Neuroinfectious Disease Continuum issue. This article and the accompanying Continuum Audio interview are available to all at continpub.com/ParaInfect until December 10, 2021.
Progression of Clinical Features in Lewy Body Dementia Can Be Detected Over 6 Months
Dr. Elie Matar discusses the progression of clinical features in Lewy Body Dementia.
Neuroprosthesis for Decoding Speech in a Paralyzed Person with Anarthria
Dr. Edward Chang discusses his paper recently published in NEJM on decoding speech in a paralyzed person with anarthria. Show reference: https://www.nejm.org/doi/full/10.1056/NEJMoa2027540
Autoantibody Results Not Clearly Correlated with Clinical Syndrome - Part 4
In part four of a four-part series, Dr. Justin Abbatemarco discusses a controversy in autoimmune neurology
Autoantibody Results Not Clearly Correlated with Clinical Syndrome - Part 3
In part three of a four-part series, Dr. Justin Abbatemarco discusses a controversy in autoimmune neurology
Cost-Effectiveness of Aducanumab
Dr. Brian Callaghan discusses the AAN's comments at a recent ICER meeting on the cost-effectiveness of aducanumab, the newly approved drug for Alzheimer's disease.
CSF α-Synuclein Real-Time Quaking-Induced Conversion Assay in Dementia With Lewy Bodies
Dr. Simone Baiardi discusses the most important points from his recent paper on dementia with Lewy bodies.
Association of Central Hypersomnia and Fatigue in Patients With Multiple Sclerosis
Dr. Anne-Laure Dubessy explores the role of central hypersomnia and fatigue in patients with MS.
Approach to Adult-Onset Cerebellar Ataxia - Part 6
In part 6 of a 6 part series, Dr. Vikram Karnik discusses the approach to adult-onset cerebellar ataxia.
Approach to Adult-Onset Cerebellar Ataxia - Part 5
In part 5 of a 6 part series, Dr. Vikram Karnik discusses the approach to adult-onset cerebellar ataxia.
Vagus Nerve Stimulation and Stroke Recovery
Dr. Halley Alexander discusses vagus nerve stimulation.
Reducing Out-of-Pocket Costs for Multiple Sclerosis Drugs
Dr. Daniel Hartung discusses out-of-pocket costs for MS drugs.
Sex, Exercise, and Other Benign Causes of Thunderclap Headache
Dr. Jonathan Smith discusses benign causes of thunderclap headache
Autoantibodies Not Clearly Correlated with A Clinical Syndrome - Part 2
In part two of a four-part series, Dr. Justin Abbatemarco discusses a controversy in autoimmune neurology.
Autoantibodies Not Clearly Correlated with A Clinical Syndrome - Part 1
In part one of a four-part series, Dr. Justin Abbatemarco discusses a controversy in autoimmune neurology.
Reducing Persistent Disability in Pediatric Multiple Sclerosis
Dr. Rae Bacharach discusses the Neurology Today article, "Robust Gains Against Persistent Disability in Pediatric MS Reported." Show reference: https://journals.lww.com/neurotodayonline/Fulltext/2021/07220/Robust_Gains_Against_Persistent_Disability_in.4.aspx
Patient Perceptions of FDA Approval
Dr. Jason Crowell discusses patient perceptions of FDA approval.
Update in the Management of Cerebral Aneurysms
Dr. Dileep Yavagal discusses the management of cerebral aneurysm.
Drug Toxicity - Part 3
In part three of a three-part series, Dr. Derek Stitt discusses drug toxicity as a cause for neurological presentation.
Drug Toxicity - Part 2
In part two of a three-part series, Dr. Derek Stitt discusses drug toxicity as a cause for neurological presentation.
Drug Toxicity - Part 1
In part one of a three-part series, Dr. Derek Stitt discusses drug toxicity as a cause for neurological presentation.
Safety and Efficacy of Coma Induction Following First-Line Treatment in Status Epilepticus: A 2-Center Study
Dr. Pia De Stefano discusses how her study findings could impact the management of status epilepticus.
Case Presentation of RCVS and Clinical Management
Dr. Andy Southerland discusses presentation and clinical management of reversible cerebral vasoconstriction syndrome (RCVS).
NIH and the History of Neurology Residency in the US
Dr. Chris Boes discusses the influence of the NIH on the history of neurology residency in the United States
Cardiovascular Health in People with Epilepsy
Dr. Halley Alexander discusses the Neurology Today article, "Higher Risk of Cardiovascular Events in Patients with Epilepsy." Show references: https://journals.lww.com/neurotodayonline/Fulltext/2021/07220/Higher_Risk_of_Cardiovascular_Events_in_Patients.7.aspx
Disparities in Dementia Evaluations for Black, Hispanic, and Asian Patients
Dr. Rae Becharach discusses the Neurology Today article, "Substantial Disparities in the Diagnosis and Comprehensiveness of Dementia Evaluations for Black, Hispanic, and Asian Patients." Show references: https://journals.lww.com/neurotodayonline/Fulltext/2021/06030/Substantial_Disparities_in_the_Diagnosis_and.8.aspx
Psychiatric Disorders in Children and Adolescents With Psychogenic Nonepileptic Seizures
Dr. Jon Stone discusses psychiatric disorders in children with psychogenic nonepileptic seizures.
Presentations of Thunderclap Headache
Dr. Alexandra Cocores discusses the top causes of thunderclap headache and its presentation.
Approach to Adult-onset Cerebellar Ataxia - Part 4
In part 4 of a 6 part series, Dr. Vikram Karnik discusses the approach to adult-onset cerebellar ataxia.
Approach to Adult-onset Cerebellar Ataxia - Part 3
In part 3 of a 6 part series, Dr. Vikram Karnik discusses the approach to adult-onset cerebellar ataxia.
Continuum: Headache
Matthew Robbins, MD, FAAN, FAHS, shares what he learned as the guest editor of the June 2021 Headache issue of Continuum. This issue is available to subscribers at ContinuumJournal.com.
Postural Orthostatic Tachycardia Syndrome (POTS)
Dr. Svetlana Blitshteyn discusses the best management approach for POTS and its link with viruses like COVID-19.
Surgical Approach to Thymectomy and Remission Rates in Myasthenia Gravis
Dr. Joseph Shrager discusses the impact of the surgical approach to thymectomy upon remission rates in myasthenia gravis.
Vaccine Response in Patients with MS
Dr. Rae Bacharach discusses the Neurology Today article, "Study Finds Greatly Reduced Immune Response to Pfizer Vaccine in MS Patients on Ocrelizumab or Fingolimod." Show references: https://journals.lww.com/neurotodayonline/Fulltext/2021/07080/Study_Finds_Greatly_Reduced_Immune_Response_to.1.aspx
Amyloid-related Imaging Abnormalities (ARIA)
Dr. Justin Abbatemarco discusses a potential complication related to anti-amyloid antibody therapy called amyloid-related imaging abnormalities (ARIA).
2021 AAN Sports Concussion Conference
Dr. Fabio Nascimento discusses the upcoming 2021 AAN Sports Concussion Conference
RCVS: Symptoms, Incidence, and Resource Utilization
Will Rondeau discusses the symptoms, incidence, and resource utilization of reversible cerebrovascular vasoconstriction syndrome with Dr. Jessica Magid-Bernstein.
Ischemic Stroke and Atrial Fibrillation: When to Start Treatment
Dr. Andy Southerland discusses the optimization of atrial fibrillation treatment and stroke prevention with Dr. Seemant Chaturvedi.
Other Primary Headache Disorders - Part 3
In part 3 of a 3 part series, Jonathan H. Smith, MD, FAHS, discusses his article, "Other Primary Headache Disorders" from the June Headache Continuum issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/OtherPrim.
Other Primary Headache Disorders - Part 2
In part 2 of a 3 part series, Jonathan H. Smith, MD, FAHS, discusses his article, "Other Primary Headache Disorders" from the June Headache Continuum issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/OtherPrim.
Other Primary Headache Disorders - Part 1
In part 1 of a 3 part series, Jonathan H. Smith, MD, FAHS, discusses his article, "Other Primary Headache Disorders" from the June Headache Continuum issue. This article and the accompanying Continuum Audio interview are available to subscribers at continpub.com/OtherPrim.
Natural History of Afferent Baroreflex Failure in Adults
Dr. Guillaume Lamotte. discusses the natural history of afferent baroreflex failure.
Havana Syndrome
Dr. Clifford Saper discusses Havana Syndrome.
Neurology Residency Accreditation in the US
Dr. Chris Boes discusses the history of neurology residency and accreditation in America.
Careers in Neurology: Neurodevelopmental Disabilities
Dr. Katherine Fu discusses neurodevelopmental disabilities
MS and COVID-19
Dr. Rae Bacharach discusses the Neurology Today article, "How Do Patients with Multiple Sclerosis Fare with COVID-19?: An MS Registry Offers Some Clues." Show references: https://journals.lww.com/neurotodayonline/Fulltext/2021/05060/How_Do_Patients_with_Multiple_Sclerosis_Fare_with.5.aspx
Neurologic Workup in New Onset Psychosis
Dr. Josep Dalmau discusses NMDAR antibodies in patients with first episode psychosis and the utility of criteria for autoimmune psychosis.
Aducanumab in Alzheimer's Disease
Dr. Daniel Gibbs discusses his Alzheimer's disease diagnosis and experience participating in a clinical trial for aducanumab. Show references: https://tattooonmybrain.com/
How to Use Patients' Sleep Tracker Data
Dr. Halley Alexander discusses the Neurology Today article, "As Consumer Sleep Trackers Gain in Popularity, Sleep Neurologists Seek More Data to Assess How to Use Them in Practice." Show references: https://journals.lww.com/neurotodayonline/fulltext/2021/05060/as_consumer_sleep_trackers_gain_in_popularity,.8.aspx